Glossary of common clinical trial terms
Clinical trial research often includes terms that may not be familiar to you. For definitions of commonly used terms, visit our glossary.
Clinical Trials
A clinical trial is a research study designed to learn how our bodies respond to medicines or other treatments.
Who can take part in a clinical trial depends on the research question the trial is trying to answer (what the trial is being done for). Some trials
recruit patients with a disease or other health condition that the clinical trial is studying. Other trials enroll healthy volunteers, which means
you do not have a specific disease or health condition.
Ideas for clinical trials usually come from researchers. Researchers !rst test new investigational treatments in a lab. The treatments with the
most promising results are moved into clinical trials to see if they are safe and work well for people.
Each clinical trial has a primary purpose – the main reason it’s being done.
Clinical trials may be paid for (sponsored) by different people or organizations, such as:
Clinical trials may take place in:
In many clinical trials, one group of participants will get the trial drug or investigational treatment being tested, while a second group, the control group, gets
either an existing (standard) treatment or a placebo (a look-alike substance that does not contain an active drug or treatment). This is done to see how well
the trial drug or investigational treatment works compared to the existing treatment or a placebo.
Side effects are any effects of a medicine, treatment, or intervention other than the main intended effect, and could be good, bad, or neutral. Investigational treatments must be tested for side effects that happen right away or afer a longer time.
Adverse events (also called adverse effects) are medical problems that happen or worsen during a clinical trial. Adverse events may or may not be caused by
the treatment a person took.
Before a clinical trial can start, it must be approved by an Independent Ethics Committee (IEC) to make sure the risks are as low as possible and are worth any
possible benefits. An IEC is a committee of doctors, data experts, community advocates, and others who help ensure that a trial is done in an ethical way and
the rights of participants are protected.
Each trial follows a carefully controlled plan (protocol) that explains what researchers will do during the trial. During the trial, researchers report the results to
the trial’s IEC, to medical journals, and to government agencies. If problems such as severe side effects happen during a trial, it may be stopped or paused to
protect participants.
Yes. Most trials study treatments related to an illness or health condition, but do not provide care for other conditions. Your doctor can also work with the
trial team to make sure that other medicines you take do not affect the trial treatment.
Yes. You can leave a clinical trial at any time. If you decide to leave a trial, talk to the trial team first. The trial team may also ask about your reasons for leaving
the trial.
If you don’t qualify for a clinical trial because of your age, health conditions, or other factors, but your doctors believe you would bene!t from
the trial treatment, sometimes you may be able to get the treatment through “expanded access.” Expanded access is sometimes called
“compassionate use” but may go by other names. Expanded access may be used to provide access to an investigational treatment for people
with a life-threatening or serious disease for which there is no good existing treatment.
Health authorities may approve expanded access for a trial treatment if:
Learn more about expanded access for specific treatments at: ClinicalTrials.gov
You can learn more about clinical trials, look up results from past trials, and find current trials at: ClinicalTrials.gov
Clinical trial research often includes terms that may not be familiar to you. For definitions of commonly used terms, visit our glossary.